603079.SH
圣达生物
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.63
−9.98%Jul 7, 2026, 07:56 UTC
Shengda Bio appointed Lin Weiyuan as board secretary and Mi Yexuan as securities affairs representative on July 6, 2026.
Source:
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
Jul 7, 2026, 07:56 UTC